Clinical Trials Browser

Not yet recruiting × Actinium × 90 days × Clear all

NCT07422363 2026-03-19

Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma

Phase 1 Not yet recruiting

Glioblastoma, Gliosarcoma

NCT07414940 2026-02-17

ACT-RESoLUTE

Phase 1/2 Not yet recruiting

Prostatic Neoplasms